Back to mobile site

Jones Trading Reiterates Buy Rating on Clearside Biomedical (CLSD)

August 27, 2024 11:11 AM EDT Send to a Friend
Jones Trading analyst Debanjana Chatterjee reiterated a Buy rating and $6.00 price target on Clearside Biomedical (NASDAQ: CLSD).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login